Large equity grants for TELA Bio, Inc. (TELA) CEO Heather Getz
Rhea-AI Filing Summary
TELA Bio, Inc. reports that Chief Executive Officer Heather C. Getz received new equity awards on August 3, 2026. She was granted 500,000 restricted stock units of common stock, increasing her holdings to 505,000 shares. She also received options for 1,365,000 shares at a $0.74 exercise price and 1,005,000 shares at $0.90, both expiring August 3, 2036. The RSUs vest in four equal annual installments beginning August 3, 2027, and each option vests 25% on that date with the remaining 75% vesting monthly over 36 months, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 500,000 shares
Net Buy
3 txns
Insider
Getz Heather C
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 1,365,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F2 | 1,005,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 500,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,370,000 shares (Direct);
Common Stock — 505,000 shares (Direct)
Footnotes (2)
- F1. These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F2. The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.
Key Figures
RSUs granted: 500,000 shares
Common stock holdings after grant: 505,000 shares
Option grant size 1: 1,365,000 shares
+5 more
8 metrics
RSUs granted
500,000 shares
Restricted stock units of common stock granted to CEO on August 3, 2026
Common stock holdings after grant
505,000 shares
Direct common stock position reported following the RSU award
Option grant size 1
1,365,000 shares
Stock options (right to buy) granted with a $0.74 exercise price
Option exercise price 1
$0.74 per share
Exercise price for 1,365,000 stock options expiring August 3, 2036
Option grant size 2
1,005,000 shares
Stock options (right to buy) granted with a $0.90 exercise price
Option exercise price 2
$0.90 per share
Exercise price for 1,005,000 stock options expiring August 3, 2036
Initial option vesting
25% on August 3, 2027
Both option grants vest 25% on August 3, 2027, subject to continued service
Remaining option vesting
75% over 36 months
Remaining 75% of each option vests in equal monthly installments over 36 months
Key Terms
restricted stock units, Stock Option (Right to Buy), exercise price, expiration date, +1 more
5 terms
restricted stock units financial
"These restricted stock units will vest in four equal annual installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 0.7400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-08-03"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The option vests 25% on August 3, 2027, with the remaining 75% vesting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did TELA (TELA) CEO Heather C. Getz receive on August 3, 2026?
Heather C. Getz received 500,000 restricted stock units of common stock and two stock option grants for 1,365,000 and 1,005,000 shares. All awards were granted on August 3, 2026, with multi-year vesting schedules tied to continued service.
How many TELA Bio (TELA) RSUs were granted to the CEO in this Form 4?
The CEO was granted 500,000 restricted stock units of TELA Bio common stock. These RSUs vest in four equal annual installments beginning on August 3, 2027, and each installment is contingent on her continued service with the company through the relevant vesting date.
What are the vesting terms of the new RSUs reported for TELA (TELA)?
The 500,000 RSUs granted to the CEO vest in four equal annual installments starting on August 3, 2027. Each annual tranche requires Heather C. Getz to remain in service with TELA Bio through the applicable vesting date to receive the shares.
What are the exercise prices and expiration dates of the new TELA (TELA) stock options?
The CEO received options for 1,365,000 shares at $0.74 per share and 1,005,000 shares at $0.90 per share. Both option grants have an expiration date of August 3, 2036, providing a ten-year term from the grant date.
How do the new TELA Bio (TELA) stock options vest for the CEO?
Each option grant vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over the following 36 months. Vesting for all portions is conditioned on Heather C. Getz’s continued service with TELA Bio.